News

The acquisition of Aton follows a number of recent acquisitions, including Brazil’s Instituto Terapeutico Delta, in March, and the April acquisition of an unnamed Brazilian company and Canada’s

Bioenergy Life Science said that Corvalen M comprises D-Ribose, a simple, 5-carbon monosaccharide, or pentose sugar. D-Ribose helps accelerate the formation of adenosine triphosphate (ATP), the primary energy

Huya said that the agreement with the School of Chinese Materia Medica of BUCM provides it with access to and first review of certain new therapeutic candidates owned

The patent, titled ‘Molecular Property Modeling Using Ranking’, describes methods for using advanced machine-learning technology to design small molecule compounds in silico that meet specific candidate drug profiles.

Kemwell has decided to increase the production capacity by expanding the production area from 16,000 to 31,000 square meters. The expansion not only makes it possible for the

ABI claimed that by taking Maxisal, cancer patients may be able to relieve at least one of the side effects of cancer therapy, dry mouth. Maxisal was first

Abhay Joshi, president and CEO of Alvine, said: “We are very pleased to add Abbott as an investor in Alvine. With the support of all our investors, we

Roche has received approvals for the anti-HCV test on three platforms like the stand-alone cobas e 411 analyzer for low-volume testing and the cobas e 601 and Modular

The study showed that infants fed with Enfamil Lipil containing DHA and ARA during the first year of life experienced improved immune outcomes, including improved respiratory health, versus